MT11 A Cost-Effectiveness Analysis of Acrysof IQ Vivity Intraocular Lens (IOL) From Private Health Fund Perspective in Australia
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1885
https://www.valueinhealthjournal.com/article/S1098-3015(22)04090-6/fulltext
Section Title :
Section Order :
11441
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04090-6&doi=10.1016/j.jval.2022.09.1885